Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Elizabeth Held

Clinical Cardiac Electrophysiology Fairfax, VA Medical Doctor

NPI 1457770919 CMS profile 4217241

8081 Innovation Park Dr Ste 602, Fairfax, VA 22031

Open in the dashboard

General payments

$84,192

56 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Elizabeth Held of Fairfax, VA is reported in the CMS Open Payments database as having received $84,192 across 56 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $366 11
2024 General $308 5
2023 General $7,928 30
2022 General $15,249 4
2021 General $20,342 4
2020 General $40,000 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Elizabeth Held
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Elizabeth Held were reported at $366. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Elizabeth Held Clinical Cardiac Electrophysiology median Middle half National median
2019 $0 $2,361 $585–$8,260 $163
2020 $40,000 $993 $247–$4,351 $114
2021 $20,342 $1,185 $326–$4,739 $132
2022 $15,249 $2,073 $554–$6,789 $149
2023 $7,928 $2,568 $759–$8,159 $160
2024 $308 $2,557 $703–$7,403 $164
2025 $366 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Boston Scientific Corporation $30,633 10 payments
  2. Medtronic Vascular, Inc. $25,000 1 payment
  3. Medtronic, Inc. $20,396 8 payments
  4. Abbott Laboratories $8,023 30 payments
  5. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $66 4 payments
  6. Biosense Webster, Inc. $29 1 payment
  7. Kestra Medical Technology Services, Inc. $27 1 payment
  8. Janssen Pharmaceuticals, Inc $18 1 payment

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Grant $75,000 4 payments
  2. Travel and Lodging $6,668 13 payments
  3. Food and Beverage $2,264 37 payments
  4. Education $260 2 payments
Products named General payments · program years 2020–2025
  1. WATCHMAN Access System Structural Heart $15,000 1 payment
  2. GENERAL - BRADY $15,000 1 payment
  3. AVEIR $4,975 7 payments
  4. ENSITE PRECISION $2,600 18 payments
  5. AMPLATZER AMULET $223 2 payments
  6. General Therapies $176 1 payment
  7. AFFERA MAPPING SYSTEM $176 3 payments
  8. TACTICATH ABLATION CATHETER, SENSOR ENABLED $169 1 payment
  9. WATCHMAN Access System Watchman_Ic $157 3 payments
  10. Micra $93 1 payment
  11. Other $419 14 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

296

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$130,025

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

43.6%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 102 $114,962
Xarelto Rivaroxaban Brand 16 $10,556
Metoprolol Succinate Generic 99 $2,854
Flecainide Acetate Generic 21 $680
Amiodarone Hcl Generic 33 $566
Diltiazem 24hr Er (Cd) Diltiazem Hcl Brand 11 $336
Pantoprazole Sodium Generic 14 $71

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 68 billing codes

Paid by Medicare

$182,032

Medicare's payments for the services billed

Medicare patients

1,059

Average age 80

Services billed

2,592

447 women, 612 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 71%
Ischemic heart disease 53%
Heart failure 51%
Arthritis 47%
Chronic kidney disease 36%
Diabetes 34%
Depression 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

56 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record